Ionis Pharmaceuticals | IONS - Interest Income


Ionis Pharmaceuticals reported $-0.66 in Interest Income for its fiscal quarter ending in December of 2024.





Interest Income Change Date
Agios Pharmaceuticals USD 10.8M 1.62M Mar/2026
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
Arrowhead Research USD 16.87M 7.18M Mar/2026
Astellas Pharma JPY 4.12B 2.94B Mar/2024
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Celltrion KRW 779M 157.66M Mar/2026
Exelixis USD 16.13M 1.3M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Kangmei Pharma CNY 2.44M 635.78K Mar/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma EUR 139K 42K Jun/2025
Medical Developments International AUD 174K 31K Dec/2024
Moderna USD 72M 2M Mar/2026
Nektar Therapeutics USD -0.18 0.07 Sep/2024
OPKO Health USD 3.01M 16K Mar/2026
Pfizer USD -0.04 115M Jun/2026
Pharma Mar EUR 1.63M 3.17M Dec/2025
Qiagen NV USD 10.56M 9.44M Mar/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sarepta Therapeutics USD 7M 1.74M Mar/2026
Sartorius EUR 14.8M 5.3M Jun/2026
Tilray USD 12.83M 20.19M May/2024
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026
Zealand Pharma A/S 74M 28.41M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.73M 3.92M Mar/2026